56 related articles for article (PubMed ID: 33369443)
1. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
Polat MC; Sönmez Ç; Yarali N; Özbek NY
Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Toso A; Bataszew A; Farfán MJ; de la Maza V; Vergara A; Valenzuela R; Torres JP
Clin Microbiol Infect; 2017 Mar; 23(3):173-178. PubMed ID: 27856269
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Peripheral Blood Cultures in Children With Cancer and Episodes of Fever and Neutropenia.
Sarquis T; Ibáñez C; De La Maza V; Valenzuela R; Zubieta M; Labraña Y; Gutiérrez V; Greppi C; Martínez D; Díaz P; Santolaya ME
Pediatr Infect Dis J; 2024 Feb; 43(2):160-164. PubMed ID: 38063512
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice guideline-inconsistent management of fever and neutropenia in pediatric oncology: A Children's Oncology Group study.
Dupuis LL; Fisher BT; Sugalski AJ; Grimes AC; Nuño M; Ramakrishnan S; Beauchemin MP; Robinson PD; Santesso N; Walsh A; Wrightson AR; Yu L; Parsons SK; Sung L
Pediatr Blood Cancer; 2024 Apr; 71(4):e30880. PubMed ID: 38291716
[TBL] [Abstract][Full Text] [Related]
5. The role of proangiogenic cytokines in predicting sepsis in febrile neutropenic children with cancer.
Çakmakcı S; Sarı N; Sönmez Ç; İlhan İE
Turk J Pediatr; 2024; 66(1):90-98. PubMed ID: 38523383
[TBL] [Abstract][Full Text] [Related]
6. "Better at home": Mixed methods report of intricacies in pediatric febrile neutropenia management.
Smeallie ET; Choi SW; Mody R; Guetterman TC; Nessle CN
Cancer Med; 2024 Mar; 13(6):e7106. PubMed ID: 38506249
[TBL] [Abstract][Full Text] [Related]
7. Secondary infections in cancer patients with febrile neutropenia.
Azap A; Bozkurt GY; Yüksel MK; Kutlu H; Topçuoğlu P; Aypak A; Akan H
Turk J Haematol; 2012 Sep; 29(3):254-8. PubMed ID: 24744669
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of withholding antimicrobial therapy in children with cancer, fever, and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Torres JP; Ibañez C; Valenzuela R; Rivera S; De la Maza V; Villarroel M; Coria P; Contardo V; Álvarez AM; Zubieta CM; Gutierrez V; Ducasse K; Martínez D; Santolaya ME
Clin Microbiol Infect; 2024 Apr; ():. PubMed ID: 38648896
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and microbiological profile of viridans group streptococci bacteremia in children with cancer and high-risk febrile neutropenia].
Cortés D; Maldonado ME; Rivacoba MC; Maza V; Valenzuela R; Payá E; Contardo V; Álvarez AM; Avilés CL; Becker A; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2020 Aug; 37(4):383-388. PubMed ID: 33399658
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
Srinivasan A; Kumar N; Scott JX
Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients-A Systematic Review.
Boeriu E; Borda A; Vulcanescu DD; Sarbu V; Arghirescu ST; Ciorica O; Bratosin F; Marincu I; Horhat FG
Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892511
[TBL] [Abstract][Full Text] [Related]
12. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
13. Predictors of severe adverse outcomes in febrile neutropenia of pediatric oncology patients at a single institute in Thailand.
Suttitossatam I; Satayasai W; Sinlapamongkolkul P; Pusongchai T; Sritipsukho P; Surapolchai P
Pediatr Hematol Oncol; 2020 Oct; 37(7):561-572. PubMed ID: 32543327
[TBL] [Abstract][Full Text] [Related]
14. Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study.
Söderman M; Rhedin S; Tolfvenstam T; Rotzén-Östlund M; Albert J; Broliden K; Lindblom A
PLoS One; 2016; 11(6):e0157398. PubMed ID: 27309354
[TBL] [Abstract][Full Text] [Related]
15. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
16. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
17. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
